Talbutal

Talbutal
Clinical data
Other names	5-(1-methylpropyl)-5-(2-propenyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
ATC code	N05CA07 (WHO) ;
Legal status
Legal status	CA: Schedule IV; US: Schedule III;
Identifiers
	IUPAC name (RS)-5-allyl-5-sec-butylpyrimidine-2,4,6(1H,3H,5H)-trione;
CAS Number	115-44-6 ;
PubChem CID	8275;
DrugBank	DB00306 ;
ChemSpider	7976 ;
UNII	4YIR8202AX;
ChEMBL	ChEMBL1200802 ;
CompTox Dashboard (EPA)	DTXSID8023630 ;
ECHA InfoCard	100.003.719
Chemical and physical data
Formula	C11H16N2O3
Molar mass	224.260 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C1NC(=O)NC(=O)C1(C(C)CC)C\C=C;
	InChI InChI=1S/C11H16N2O3/c1-4-6-11(7(3)5-2)8(14)12-10(16)13-9(11)15/h4,7H,1,5-6H2,2-3H3,(H2,12,13,14,15,16) ; Key:BJVVMKUXKQHWJK-UHFFFAOYSA-N ;
	(what is this?) (verify)

Talbutal (Lotusate) is a barbiturate with a short to intermediate duration of action. It is a structural isomer of butalbital. Talbutal is a schedule III drug in the U.S.